Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The daily Top 10 COVID papers


  Influenza

  Free Subscription


28.12.2020

8 Ann Intern Med
1 Biochemistry
5 BMJ
4 Cell
2 Drugs
2 Epidemiol Infect
1 J Exp Med
1 J Gen Virol
1 J Immunol
9 J Infect Dis
1 J Virol
6 J Virol Methods
5 JAMA
4 N Engl J Med
28 PLoS One
6 Proc Natl Acad Sci U S A
4 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. EPELBAUM O
    Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.
    Ann Intern Med. 2020;173:1029-1030.
    PubMed        

  2. HVIID A
    Vaccine Safety in Pregnancy: Going Beyond the Perinatal Period.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-5489.
    PubMed        

  3. GORMLEY M
    SARS-CoV-2: The Growing Case for Potential Transmission in a Building via Wastewater Plumbing Systems.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-6134.
    PubMed        

  4. QASEEM A, Etxeandia-Ikobaltzeta I, Yost J, Humphrey LL, et al
    Update Alert: Use of N95, Surgical, or Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1).
    Ann Intern Med. 2020 Oct 27. doi: 10.7326/L20-1268.
    PubMed        

  5. MACKEY K, Kansagara D, Vela K
    Update Alert 5: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults.
    Ann Intern Med. 2020 Oct 27. doi: 10.7326/L20-1293.
    PubMed        

  6. CHOU R, Dana T, Jungbauer R, Weeks C, et al
    Update Alert 3: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings.
    Ann Intern Med. 2020 Oct 27. doi: 10.7326/L20-1292.
    PubMed        

  7. CARPENTER CR
    Rapid antigen and molecular tests had varied sensitivity and >/=97% specificity for detecting SARS-CoV-2 infection.
    Ann Intern Med. 2020;173:JC69.
    PubMed         Abstract available

  8. WICHMANN D
    Autopsy Findings and Venous Thromboembolism in Patients With COVID-19.
    Ann Intern Med. 2020;173:1030.
    PubMed        


    Biochemistry

  9. BHADRA S, Maranhao AC, Paik I, Ellington AD, et al
    One-Enzyme Reverse Transcription qPCR Using Taq DNA Polymerase.
    Biochemistry. 2020;59:4638-4645.
    PubMed         Abstract available


    BMJ

  10. NABAVI N
    The new normal.
    BMJ. 2020;371:m4732.
    PubMed        

  11. BURGESS S, Smith D, Kenyon JC, Gill D, et al
    Lightening the viral load to lessen covid-19 severity.
    BMJ. 2020;371:m4763.
    PubMed        

  12. DEEKS JJ, Raffle AE
    Lateral flow tests cannot rule out SARS-CoV-2 infection.
    BMJ. 2020;371:m4787.
    PubMed        

  13. GILL D, Ponsford MJ
    Testing for antibodies to SARS-CoV-2.
    BMJ. 2020;371:m4288.
    PubMed        

  14. SINHA I
    Lockdowns don't kill women, abusive men do.
    BMJ. 2020;371:m4795.
    PubMed        


    Cell

  15. GHOSH S, Dellibovi-Ragheb TA, Kerviel A, Pak E, et al
    beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway.
    Cell. 2020;183:1520-1535.
    PubMed         Abstract available

  16. CHEN Y, Zuiani A, Fischinger S, Mullur J, et al
    Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
    Cell. 2020;183:1496-1507.
    PubMed         Abstract available

  17. SU Y, Chen D, Yuan D, Lausted C, et al
    Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.
    Cell. 2020;183:1479-1495.
    PubMed         Abstract available

  18. ZOHAR T, Loos C, Fischinger S, Atyeo C, et al
    Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.
    Cell. 2020;183:1508-1519.
    PubMed         Abstract available


    Drugs

  19. LIN KJ, Schneeweiss S, Tesfaye H, D'Andrea E, et al
    Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity.
    Drugs. 2020;80:1961-1972.
    PubMed         Abstract available

  20. CANTINI F, Goletti D, Petrone L, Najafi Fard S, et al
    Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
    Drugs. 2020 Oct 17. pii: 10.1007/s40265-020-01421.
    PubMed         Abstract available


    Epidemiol Infect

  21. MO P, Deng L, Liu X, Gao S, et al
    Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study.
    Epidemiol Infect. 2020;148:e293.
    PubMed         Abstract available

  22. DE ALMEIDA GB, Pronunciate M, Grotto RMT, Azevedo Pugliesi E, et al
    Two hundred days of COVID-19 in Sao Paulo State, Brazil.
    Epidemiol Infect. 2020;148:e295.
    PubMed         Abstract available


    J Exp Med

  23. BRYANT C
    COVID-19 stokes inflammasomes.
    J Exp Med. 2021;218.
    PubMed         Abstract available


    J Gen Virol

  24. KLIMSTRA WB, Tilston-Lunel NL, Nambulli S, Boslett J, et al
    SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
    J Gen Virol. 2020;101:1156-1169.
    PubMed         Abstract available


    J Immunol

  25. VOGELZANG EH, Loeff FC, Derksen NIL, Kruithof S, et al
    Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
    J Immunol. 2020;205:3491-3499.
    PubMed         Abstract available


    J Infect Dis

  26. SCHIEFFELIN JS
    Infectious Disease Outbreaks: The Need For an All-in Approach.
    J Infect Dis. 2020;222:1941-1942.
    PubMed        

  27. HALSTEAD SB, Katzelnick L
    COVID 19 Vaccines: Should we fear ADE?
    J Infect Dis. 2020 Aug 12. pii: 5891764. doi: 10.1093.
    PubMed         Abstract available

  28. GNIFFKE EP, Harrington WE, Dambrauskas N, Jiang Y, et al
    Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.
    J Infect Dis. 2020;222:1965-1973.
    PubMed         Abstract available

  29. NARANBHAI V, Chang CC, Beltran WFG, Miller TE, et al
    High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
    J Infect Dis. 2020;222:1955-1959.
    PubMed         Abstract available

  30. BENNER SE, Patel EU, Laeyendecker O, Pekosz A, et al
    SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
    J Infect Dis. 2020;222:1974-1984.
    PubMed         Abstract available

  31. VITTE J, Diallo AB, Boumaza A, Lopez A, et al
    A Granulocytic Signature Identifies COVID-19 and Its Severity.
    J Infect Dis. 2020;222:1985-1996.
    PubMed         Abstract available

  32. SCHWAIGER J, Karbiener M, Aberham C, Farcet MR, et al
    No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
    J Infect Dis. 2020;222:1960-1964.
    PubMed         Abstract available

  33. TAN TQ, Kullar R, Swartz TH, Mathew TA, et al
    Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1951-1954.
    PubMed         Abstract available

  34. KUBALE J, Balmaseda A, Sanchez N, Lopez R, et al
    Pneumonia following symptomatic influenza infection among Nicaraguan children before and after introduction of the pneumococcal conjugate vaccine.
    J Infect Dis. 2020 Dec 22. pii: 6044070. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  35. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    PubMed         Abstract available


    J Virol Methods

  36. BELTRAN-PAVEZ C, Alonso-Palomares LA, Valiente-Echeverria F, Gaggero A, et al
    Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction.
    J Virol Methods. 2021;287:113969.
    PubMed         Abstract available

  37. KRUTTGEN A, Cornelissen CG, Dreher M, Hornef MW, et al
    Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
    J Virol Methods. 2021;287:113978.
    PubMed         Abstract available

  38. PARK JG, Oladunni FS, Chiem K, Ye C, et al
    Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
    J Virol Methods. 2021;287:113995.
    PubMed         Abstract available

  39. KULKARNI R, Patil HP, Palkar S, Lalwani S, et al
    Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using beta-propiolactone-inactivated, whole virus-based indirect ELISA.
    J Virol Methods. 2021;287:113996.
    PubMed         Abstract available

  40. DU J, Chu E, Zhang D, Lu CM, et al
    A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19.
    J Virol Methods. 2021;287:114009.
    PubMed         Abstract available

  41. AMBROSI C, Prezioso C, Checconi P, Scribano D, et al
    SARS-CoV-2: Comparative analysis of different RNA extraction methods.
    J Virol Methods. 2021;287:114008.
    PubMed         Abstract available


    JAMA

  42. DESAI AN, Majumder MS
    What Is Herd Immunity?
    JAMA. 2020;324:2113.
    PubMed        

  43. BAKER DW
    Trust in Health Care in the Time of COVID-19.
    JAMA. 2020;324:2373-2375.
    PubMed        

  44. HUSKAMP HA, Busch AB, Uscher-Pines L, Barnett ML, et al
    Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic.
    JAMA. 2020;324:2440-2442.
    PubMed        

  45. CANCE JD, Doyle E
    Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.
    JAMA. 2020;324:2442-2444.
    PubMed        


  46. Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More.
    JAMA. 2020;324:2354-2355.
    PubMed        


    N Engl J Med

  47. GOLDMAN JD, Osinusi A, Marty FM
    Racial Disproportionality in Covid Clinical Trials.
    N Engl J Med. 2020;383:2486-2487.
    PubMed        

  48. TOMASHEK KM, Mehta AK, Hynes NA
    Racial Disproportionality in Covid Clinical Trials.
    N Engl J Med. 2020;383:2487-2488.
    PubMed        

  49. CHASTAIN DB, Henao-Martinez AF, Young HN
    Racial Disproportionality in Covid Clinical Trials. Reply.
    N Engl J Med. 2020;383:2488-2490.
    PubMed        

  50. MICHAEL NL
    SARS-CoV-2 in the U.S. Military - Lessons for Civil Society.
    N Engl J Med. 2020 Nov 11. doi: 10.1056/NEJMe2032179.
    PubMed        


    PLoS One

  51. KAWASUJI H, Takegoshi Y, Kaneda M, Ueno A, et al
    Transmissibility of COVID-19 depends on the viral load around onset in adult and symptomatic patients.
    PLoS One. 2020;15:e0243597.
    PubMed         Abstract available

  52. O'DONNELL A, Wilson L, Bosch JA, Borrows R, et al
    Life satisfaction and happiness in patients shielding from the COVID-19 global pandemic: A randomised controlled study of the 'mood as information' theory.
    PLoS One. 2020;15:e0243278.
    PubMed         Abstract available

  53. KIM W, Lee H, Chung YD
    Safe contact tracing for COVID-19: A method without privacy breach using functional encryption techniques based-on spatio-temporal trajectory data.
    PLoS One. 2020;15:e0242758.
    PubMed         Abstract available

  54. NOREEN K, Rubab ZE, Umar M, Rehman R, et al
    Knowledge, attitudes, and practices against the growing threat of COVID-19 among medical students of Pakistan.
    PLoS One. 2020;15:e0243696.
    PubMed         Abstract available

  55. MORSE JW, Gladkikh TM, Hackenburg DM, Gould RK, et al
    COVID-19 and human-nature relationships: Vermonters' activities in nature and associated nonmaterial values during the pandemic.
    PLoS One. 2020;15:e0243697.
    PubMed         Abstract available

  56. BAZAID AS, Aldarhami A, Binsaleh NK, Sherwani S, et al
    Knowledge and practice of personal protective measures during the COVID-19 pandemic: A cross-sectional study in Saudi Arabia.
    PLoS One. 2020;15:e0243695.
    PubMed         Abstract available

  57. JACOBS LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, et al
    Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection.
    PLoS One. 2020;15:e0243882.
    PubMed         Abstract available

  58. AHMED I, Hasan M, Akter R, Sarkar BK, et al
    Behavioral preventive measures and the use of medicines and herbal products among the public in response to Covid-19 in Bangladesh: A cross-sectional study.
    PLoS One. 2020;15:e0243706.
    PubMed         Abstract available

  59. SILVERBERG SL, Puchalski Ritchie LM, Gobat N, Nichol A, et al
    Clinician-researcher's perspectives on clinical research during the COVID19 pandemic.
    PLoS One. 2020;15:e0243525.
    PubMed         Abstract available

  60. BAIG M, Jameel T, Alzahrani SH, Mirza AA, et al
    Predictors of misconceptions, knowledge, attitudes, and practices of COVID-19 pandemic among a sample of Saudi population.
    PLoS One. 2020;15:e0243526.
    PubMed         Abstract available

  61. KOBO O, Efraim R, Saada M, Kofman N, et al
    The impact of lockdown enforcement during the SARSCoV-2 pandemic on the timing of presentation and early outcomes of patients with ST-elevation myocardial infarction.
    PLoS One. 2020;15:e0241149.
    PubMed         Abstract available

  62. CHOW DS, Glavis-Bloom J, Soun JE, Weinberg B, et al
    Development and external validation of a prognostic tool for COVID-19 critical disease.
    PLoS One. 2020;15:e0242953.
    PubMed         Abstract available

  63. KIM R, Nachman S, Fernandes R, Meyers K, et al
    Comparison of COVID-19 infections among healthcare workers and non-healthcare workers.
    PLoS One. 2020;15:e0241956.
    PubMed         Abstract available

  64. RANA MM, Karim MR, Wadood MA, Kabir MM, et al
    Knowledge of prevention of COVID-19 among the general people in Bangladesh: A cross-sectional study in Rajshahi district.
    PLoS One. 2020;15:e0243410.
    PubMed         Abstract available

  65. BERTSIMAS D, Lukin G, Mingardi L, Nohadani O, et al
    COVID-19 mortality risk assessment: An international multi-center study.
    PLoS One. 2020;15:e0243262.
    PubMed         Abstract available

  66. TRUBIANO JA, Vogrin S, Smibert OC, Marhoon N, et al
    COVID-MATCH65-A prospectively derived clinical decision rule for severe acute respiratory syndrome coronavirus 2.
    PLoS One. 2020;15:e0243414.
    PubMed         Abstract available

  67. FUDOLIG M, Howard R
    The local stability of a modified multi-strain SIR model for emerging viral strains.
    PLoS One. 2020;15:e0243408.
    PubMed         Abstract available

  68. PAEK JH, Kim Y, Park WY, Jin K, et al
    Severe acute kidney injury in COVID-19 patients is associated with in-hospital mortality.
    PLoS One. 2020;15:e0243528.
    PubMed         Abstract available

  69. NASCIMENTO MS, Baggio DM, Fascina LP, do Prado C, et al
    Impact of social isolation due to COVID-19 on the seasonality of pediatric respiratory diseases.
    PLoS One. 2020;15:e0243694.
    PubMed         Abstract available

  70. KALIA V, Knauft K, Hayatbini N
    Cognitive flexibility and perceived threat from COVID-19 mediate the relationship between childhood maltreatment and state anxiety.
    PLoS One. 2020;15:e0243881.
    PubMed         Abstract available

  71. DE BRIER N, Stroobants S, Vandekerckhove P, De Buck E, et al
    Factors affecting mental health of health care workers during coronavirus disease outbreaks (SARS, MERS & COVID-19): A rapid systematic review.
    PLoS One. 2020;15:e0244052.
    PubMed         Abstract available

  72. THOMSON RJ, Hunter J, Dutton J, Schneider J, et al
    Clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to an intensive care unit in London: A prospective observational cohort study.
    PLoS One. 2020;15:e0243710.
    PubMed         Abstract available

  73. SOURIS M, Gonzalez JP
    COVID-19: Spatial analysis of hospital case-fatality rate in France.
    PLoS One. 2020;15:e0243606.
    PubMed         Abstract available

  74. MOAZZAMI B, Chaichian S, Kasaeian A, Djalalinia S, et al
    Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0243600.
    PubMed         Abstract available

  75. CORREA TD, Cordioli RL, Campos Guerra JC, Caldin da Silva B, et al
    Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory study.
    PLoS One. 2020;15:e0243604.
    PubMed         Abstract available

  76. ALBADR MAA, Tiun S, Ayob M, Al-Dhief FT, et al
    Optimised genetic algorithm-extreme learning machine approach for automatic COVID-19 detection.
    PLoS One. 2020;15:e0242899.
    PubMed         Abstract available

  77. BARYCKA K, Szarpak L, Filipiak KJ, Jaguszewski M, et al
    Comparative effectiveness of N95 respirators and surgical/face masks in preventing airborne infections in the era of SARS-CoV2 pandemic: A meta-analysis of randomized trials.
    PLoS One. 2020;15:e0242901.
    PubMed         Abstract available

  78. AL-ASHWAL FY, Kubas M, Zawiah M, Bitar AN, et al
    Healthcare workers' knowledge, preparedness, counselling practices, and perceived barriers to confront COVID-19: A cross-sectional study from a war-torn country, Yemen.
    PLoS One. 2020;15:e0243962.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  79. CARLETON T, Cornetet J, Huybers P, Meng KC, et al
    Global evidence for ultraviolet radiation decreasing COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  80. CIPPA PE, Cugnata F, Ferrari P, Brombin C, et al
    A data-driven approach to identify risk profiles and protective drugs in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  81. ZANG R, Case JB, Yutuc E, Ma X, et al
    Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
    Proc Natl Acad Sci U S A. 2020;117:32105-32113.
    PubMed         Abstract available

  82. TUPPER P, Boury H, Yerlanov M, Colijn C, et al
    Event-specific interventions to minimize COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:32038-32045.
    PubMed         Abstract available

  83. TAYLOR CA, Boulos C, Almond D
    Livestock plants and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:31706-31715.
    PubMed         Abstract available

  84. CHEN MK, Chevalier JA, Long EF
    Nursing home staff networks and COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Vaccine

  85. SCHMIT T, Kuntz M, Patel D, Nadeem Khan M, et al
    Anti-capsular immunity to Streptococcus pneumoniae serotype 22F prevents bacterial transmission in murine colonization and influenza virus co-infection models.
    Vaccine. 2020 Dec 18. pii: S0264-410X(20)31558.
    PubMed         Abstract available

  86. RASTEGAR M, Tavana M, Meraj A, Mina H, et al
    An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31589.
    PubMed         Abstract available

  87. SPARROW E, Wood JG, Chadwick C, Newall AT, et al
    Global production capacity of seasonal and pandemic influenza vaccines in 2019.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31585.
    PubMed         Abstract available

  88. FULVINI AA, Tuteja A, Le J, Pokorny BA, et al
    HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31563.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: